Dr. Muhammad Taqi, M.D
NPI: 1013123280
Total Payments
$102,238
2024 Payments
$2,521
Companies
44
Transactions
333
Medicare Patients
8,041
Medicare Billing
$1.7M
Payment Breakdown by Category
Other$30,950 (30.3%)
Consulting$26,200 (25.6%)
Food & Beverage$19,256 (18.8%)
Travel$18,860 (18.4%)
Research$6,913 (6.8%)
Education$59.18 (0.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $30,950 | 6 | 30.3% |
| Consulting Fee | $26,200 | 12 | 25.6% |
| Food and Beverage | $19,256 | 282 | 18.8% |
| Travel and Lodging | $18,860 | 28 | 18.4% |
| Unspecified | $6,913 | 3 | 6.8% |
| Education | $59.18 | 2 | 0.1% |
Payments by Type
General
$95,326
330 transactions
Research
$6,913
3 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Rapid Medical Ltd | $50,879 | 16 | $0 (2023) |
| Stryker Corporation | $22,931 | 90 | $0 (2024) |
| Medtronic, Inc. | $8,737 | 21 | $0 (2024) |
| Penumbra, Inc. | $4,720 | 28 | $0 (2024) |
| Balt USA, LLC | $3,755 | 19 | $0 (2024) |
| Medtronic USA, Inc. | $3,010 | 14 | $0 (2020) |
| Silk Road Medical, Inc. | $1,211 | 11 | $0 (2020) |
| DePuy Synthes Sales Inc. | $919.95 | 19 | $0 (2024) |
| Medtronic Vascular, Inc. | $910.04 | 8 | $0 (2017) |
| Edwards Lifesciences Corporation | $729.07 | 8 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,521 | 46 | Stryker Corporation ($727.55) |
| 2023 | $15,755 | 34 | Rapid Medical Ltd ($10,000) |
| 2022 | $6,977 | 38 | Medtronic, Inc. ($4,012) |
| 2021 | $3,329 | 31 | Medtronic, Inc. ($1,120) |
| 2020 | $7,221 | 33 | Penumbra, Inc. ($2,675) |
| 2019 | $46,256 | 51 | Rapid Medical LTD ($38,660) |
| 2018 | $2,849 | 30 | Stryker Corporation ($1,899) |
| 2017 | $17,329 | 70 | Stryker Corporation ($15,207) |
All Payment Transactions
333 individual payment records from CMS Open Payments — Page 1 of 14
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/21/2024 | Medtronic, Inc. | PIPELINE (Device) | Food and Beverage | In-kind items and services | $105.21 | General |
| Category: Flow Diversion | ||||||
| 12/21/2024 | Stryker Corporation | TREVO (Device), SURPASS EVOLVE, TARGET | Food and Beverage | In-kind items and services | $97.71 | General |
| Category: MICROCATHETERSTENTRIEVER | ||||||
| 12/20/2024 | Penumbra, Inc. | Penumbra System (Device) | Food and Beverage | Cash or cash equivalent | $139.67 | General |
| Category: Neurointervention | ||||||
| 12/20/2024 | Balt USA, LLC | Optima Coil System | Food and Beverage | In-kind items and services | $78.06 | General |
| 12/16/2024 | ABBVIE INC. | BOTOX (Biological), QULIPTA | Food and Beverage | In-kind items and services | $15.10 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 12/11/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $23.57 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 11/25/2024 | ABBVIE INC. | BOTOX (Biological), QULIPTA | Food and Beverage | In-kind items and services | $9.82 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 11/17/2024 | Grifols USA, LLC | Gamunex-C (Biological) | Food and Beverage | In-kind items and services | $25.98 | General |
| Category: Immunology and Neurology | ||||||
| 11/13/2024 | XTANT MEDICAL INC | — | Food and Beverage | Cash or cash equivalent | $120.65 | General |
| 11/13/2024 | AstraZeneca Pharmaceuticals LP | ANDEXXA (Biological) | Food and Beverage | In-kind items and services | $31.19 | General |
| Category: Rare Disease | ||||||
| 10/30/2024 | Stryker Corporation | TREVO (Device), WINGSPAN, TARGET | Food and Beverage | In-kind items and services | $134.62 | General |
| Category: MICROCATHETERSTENTRIEVER | ||||||
| 10/28/2024 | Stryker Corporation | TREVO (Device), WINGSPAN, TARGET | Food and Beverage | In-kind items and services | $33.33 | General |
| Category: MICROCATHETERSTENTRIEVER | ||||||
| 10/22/2024 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $28.89 | General |
| Category: NEUROSCIENCE | ||||||
| 10/17/2024 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $12.38 | General |
| Category: NEUROSCIENCE | ||||||
| 10/16/2024 | Microtransponder, Inc. | — | Food and Beverage | Cash or cash equivalent | $28.80 | General |
| 10/07/2024 | Grifols USA, LLC | Gamunex-C (Biological) | Food and Beverage | In-kind items and services | $17.85 | General |
| Category: Immunology and Neurology | ||||||
| 09/12/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $7.73 | General |
| Category: NEUROSCIENCE | ||||||
| 08/22/2024 | AstraZeneca Pharmaceuticals LP | ANDEXXA (Biological) | Education | In-kind items and services | $32.30 | General |
| Category: Rare Disease | ||||||
| 08/22/2024 | AstraZeneca Pharmaceuticals LP | ANDEXXA (Biological) | Education | In-kind items and services | $26.88 | General |
| Category: Rare Disease | ||||||
| 08/22/2024 | AstraZeneca Pharmaceuticals LP | ANDEXXA (Biological) | Food and Beverage | In-kind items and services | $20.79 | General |
| Category: Rare Disease | ||||||
| 08/21/2024 | AstraZeneca Pharmaceuticals LP | ANDEXXA (Biological) | Food and Beverage | In-kind items and services | $9.83 | General |
| Category: Rare Disease | ||||||
| 08/19/2024 | Stryker Corporation | TREVO (Device), WINGSPAN | Food and Beverage | In-kind items and services | $111.57 | General |
| Category: MICROCATHETERSTENTRIEVER | ||||||
| 08/13/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $24.33 | General |
| Category: NEUROSCIENCE | ||||||
| 08/09/2024 | DePuy Synthes Sales Inc. | EMBOGUARD (Device) | Food and Beverage | In-kind items and services | $43.35 | General |
| Category: Neurovascular | ||||||
| 07/25/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $14.03 | General |
| Category: NEUROSCIENCE | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| ELEVATE Study | Medtronic, Inc. | $4,813 | 2 |
| ELEVATE Study | Medtronic USA, Inc. | $2,100 | 1 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 29 | 2,186 | 3,149 | $3.2M | $431,134 |
| 2022 | 24 | 1,756 | 2,762 | $2.6M | $344,745 |
| 2021 | 26 | 1,873 | 2,985 | $6.7M | $435,173 |
| 2020 | 21 | 2,226 | 3,872 | $7.4M | $518,855 |
Total Patients
8,041
Total Services
12,768
Medicare Billing
$1.7M
Procedure Codes
101
All Medicare Procedures & Services
101 procedure records from CMS Medicare Utilization — Page 1 of 5
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99291 | Critical care, first 30-74 minutes | Facility | 2023 | 214 | 598 | $617,925 | $103,865 | 16.8% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 258 | 501 | $229,912 | $49,359 | 21.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 300 | 425 | $179,600 | $45,809 | 25.5% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 238 | 290 | $203,235 | $41,554 | 20.4% |
| 36224 | Insertion of tube into internal neck artery for diagnosis or treatment with review by radiologist | Facility | 2023 | 76 | 84 | $532,676 | $26,822 | 5.0% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 134 | 153 | $91,048 | $23,302 | 25.6% |
| 36226 | Insertion of tube into brain artery for diagnosis or treatment with review by radiologist | Facility | 2023 | 82 | 86 | $521,864 | $18,755 | 3.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 192 | 230 | $58,395 | $15,480 | 26.5% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 78 | 78 | $57,642 | $14,134 | 24.5% |
| 61645 | Removal of blood clot and injection to dissolve blood clot from head artery using fluoroscopic guidance | Facility | 2023 | 17 | 17 | $50,002 | $10,120 | 20.2% |
| 95816 | Measurement of brain wave activity (eeg), awake and drowsy | Office | 2023 | 31 | 34 | $41,370 | $9,902 | 23.9% |
| 37215 | Insertion of stent and blood clot protection device in neck artery with review by radiologist | Facility | 2023 | 13 | 13 | $53,772 | $9,095 | 16.9% |
| 93923 | Complete ultrasound study of arm and leg arteries | Office | 2023 | 48 | 79 | $39,255 | $8,707 | 22.2% |
| 61626 | Occlusion of head or neck artery | Facility | 2023 | 11 | 13 | $72,878 | $7,387 | 10.1% |
| 99292 | Critical care, each additional 30 minutes | Facility | 2023 | 52 | 69 | $29,234 | $6,032 | 20.6% |
| 36228 | Insertion of tube into neck or brain artery for diagnosis or treatment with review by radiologist | Facility | 2023 | 21 | 24 | $94,382 | $5,984 | 6.3% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 60 | 87 | $16,656 | $5,728 | 34.4% |
| 95923 | Testing of autonomic (sympathetic) nervous system function | Office | 2023 | 45 | 45 | $20,528 | $5,001 | 24.4% |
| 36222 | Insertion of tube into extracranial artery for diagnosis or treatment with review by radiologist | Facility | 2023 | 25 | 25 | $87,785 | $4,565 | 5.2% |
| 36227 | Insertion of tube into external neck artery for diagnosis or treatment with review by radiologist | Facility | 2023 | 36 | 36 | $40,589 | $4,304 | 10.6% |
| 95921 | Testing of autonomic nervous system function and heart rate response to deep breathing | Office | 2023 | 46 | 46 | $14,172 | $3,568 | 25.2% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 19 | 19 | $10,877 | $2,681 | 24.7% |
| 36225 | Insertion of tube into chest artery for diagnosis or treatment with review by radiologist | Facility | 2023 | 16 | 16 | $68,420 | $2,180 | 3.2% |
| 75898 | Imaging of blood vessel | Facility | 2023 | 20 | 22 | $6,272 | $1,590 | 25.3% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 14 | 14 | $5,600 | $1,244 | 22.2% |
About Dr. Muhammad Taqi, M.D
Dr. Muhammad Taqi, M.D is a Student in an Organized Health Care Education/Training Program healthcare provider based in Palm Springs, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/15/2007. The National Provider Identifier (NPI) number assigned to this provider is 1013123280.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Muhammad Taqi, M.D has received a total of $102,238 in payments from pharmaceutical and medical device companies, with $2,521 received in 2024. These payments were reported across 333 transactions from 44 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($30,950).
As a Medicare-enrolled provider, Taqi has provided services to 8,041 Medicare beneficiaries, totaling 12,768 services with total Medicare billing of $1.7M. Data is available for 4 years (2020–2023), covering 101 distinct procedure/service records.
Ad
Practice Information
- Specialty Student in an Organized Health Care Education/Training Program
- Other Specialties Vascular Neurology, Vascular Neurology
- Location Palm Springs, CA
- Active Since 05/15/2007
- Last Updated 04/21/2022
- Taxonomy Code 390200000X
- Entity Type Individual
- NPI Number 1013123280
Products in Payments
- Comaneci (Device) $38,956
- TIGERTRIEVER 17 REVASCULARIZATION DEVICE (Device) $11,532
- NEW PRODUCT DEVELOPMENT (Device) $8,265
- Neuroform EZ (Device) $3,805
- Optima Thermal Coil System (Device) $2,731
- Penumbra SMART Coil (Device) $2,491
- TREVO (Device) $2,164
- Penumbra System (Device) $1,663
- New Product Development (Device) $1,518
- Trevo (Device) $1,372
- PIPELINE (Device) $1,350
- ENROUTE Transcarotid Neuroprotection System (Device) $1,211
- SURPASS EVOLVE (Device) $1,129
- SOLITAIRE X (Device) $1,105
- SURPASS (Device) $1,025
- Pipeline (Device) $1,017
- Target (Device) $978.93
- Solitaire (Device) $839.55
- WINGSPAN (Device) $800.00
- TARGET (Device) $681.51
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Student in an Organized Health Care Education/Training Program Doctors in Palm Springs
Dr. Santa Kerzuma, D.o, D.O
Student in an Organized Health Care Education/Training Program — Payments: $4,878
Student in an Organized Health Care Education/Training Program $4,878
Sara Rasekhi
Student in an Organized Health Care Education/Training Program — Payments: $3,409
Student in an Organized Health Care Education/Training Program $3,409
Mrs. Lynn Fontana
Student in an Organized Health Care Education/Training Program — Payments: $1,497
Student in an Organized Health Care Education/Training Program $1,497
Dr. Rebecca Houston
Student in an Organized Health Care Education/Training Program — Payments: $1,496
Student in an Organized Health Care Education/Training Program $1,496
Dr. Jamie Robinson, Fnp-C, FNP-C
Student in an Organized Health Care Education/Training Program — Payments: $1,456
Student in an Organized Health Care Education/Training Program $1,456
Abdallah Abu-Samrah, M.d, M.D
Student in an Organized Health Care Education/Training Program — Payments: $938.83
Student in an Organized Health Care Education/Training Program $938.83